We demonstrated that the titer of anti-MDA5 Ab is increased in the plasma of COVID-19 patients as compared with healthy controls (1.85 ± 0.67 vs 6.60 ± 5.50, P<0.0001) (Figure 1B). Here, IFIH1 is linked to COVID-19.